Endothelial Dysfunction in Neurodegenerative Diseases

Endothelial Dysfunction in Neurodegenerative Diseases

The cerebral vascular system stringently regulates cerebral blood flow (CBF). The components of the blood–brain barrier (BBB) protect the brain from pathogenic infections and harmful substances, efflux waste, and exchange substances; however, diseases develop in cases of blood vessel injuries and BB...

Full description

Bibliographic Details
Main Authors:	Yao-Ching Fang, Yi-Chen Hsieh, Chaur-Jong Hu, Yong-Kwang Tu
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	International Journal of Molecular Sciences
Subjects:	cerebral blood flow (CBF) blood–brain barrier (BBB) Alzheimer’s disease (AD) vascular dementia (VaD)
Online Access:	https://www.mdpi.com/1422-0067/24/3/2909

Similar Items

Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors
by: Sarah Lecordier, et al.
Published: (2021-09-01)

Contribution of blood-brain barrier-related blood-borne factors for Alzheimer’s disease vs. vascular dementia diagnosis: A pilot study
by: Min Gong, et al.
Published: (2022-08-01)

20-HETE Enzymes and Receptors in the Neurovascular Unit: Implications in Cerebrovascular Disease
by: Ezekiel Gonzalez-Fernandez, et al.
Published: (2020-09-01)

Case Report of a pathologically confirmed vascular parkinsonism with early cognitive impairment and Behavioral disturbance
by: Shouzi Zhang, et al.
Published: (2021-01-01)

Serum Amyloid Biomarkers, Tau Protein and YKL-40 Utility in Detection, Differential Diagnosing, and Monitoring of Dementia
by: Karolina Wilczyńska, et al.
Published: (2021-09-01)

Dysfunction of the Blood-Brain Barrier—A Key Step in Neurodegeneration and Dementia
by: Christian R. Noe, et al.
Published: (2020-07-01)

Understanding brain function in vascular cognitive impairment and dementia with EEG and MEG: A systematic review
by: Lucía Torres-Simón, et al.
Published: (2022-01-01)

Amyloid β oligomer induces cerebral vasculopathy via pericyte-mediated endothelial dysfunction
by: Siqi Chen, et al.
Published: (2024-03-01)

Accelerating the in vitro emulation of Alzheimer’s disease-associated phenotypes using a novel 3D blood-brain barrier neurosphere co-culture model
by: Eunkyung Clare Ko, et al.
Published: (2023-10-01)

Microfluidics-Based Systems in Diagnosis of Alzheimer’s Disease and Biomimetic Modeling
by: Yan Li, et al.
Published: (2020-08-01)

Involvement of single nucleotide polymorphisms of junction adhesion molecule with small vessel vascular dementia
by: Peter Xie, et al.
Published: (2023-12-01)

Study of visuospatial skill in patients with dementia
by: Asutosh Pal, et al.
Published: (2016-01-01)

Chronic Low Dose Morphine Does Not Alter Two In Vitro BBB Models
by: Jamie Marino, et al.
Published: (2022-07-01)

Early therapeutic effects of an Angiopoietin-1 mimetic peptide in middle-aged rats with vascular dementia
by: Huanjia Gao, et al.
Published: (2023-05-01)

Treatment With an Angiopoietin-1 Mimetic Peptide Improves Cognitive Outcome in Rats With Vascular Dementia
by: Lauren Culmone, et al.
Published: (2022-05-01)

Identifying effective diagnostic biomarkers for childhood cerebral malaria in Africa integrating coexpression analysis with machine learning algorithm
by: Jia-Xin Li, et al.
Published: (2023-02-01)

CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
by: János Haskó, et al.
Published: (2014-05-01)

Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer’s Disease
by: Yara Mashal, et al.
Published: (2022-07-01)

Analysis of Cerebral Small Vessel Changes in AD Model Mice
by: Abu Zaffar Shibly, et al.
Published: (2022-12-01)

The role of melatonin in the onset and progression of type 3 diabetes
by: Juhyun Song, et al.
Published: (2017-08-01)

Exploratory Transcriptomic Profiling Reveals the Role of Gut Microbiota in Vascular Dementia
by: Navdeep Kaur, et al.
Published: (2023-04-01)

Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
by: Amer E. Alkhalifa, et al.
Published: (2023-11-01)

Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors
by: Jessica I. Griffith, et al.
Published: (2020-12-01)

Peptide Shuttles for Blood–Brain Barrier Drug Delivery
by: Macarena Sánchez-Navarro, et al.
Published: (2022-09-01)

Retinal and Cortical Blood Flow Dynamics Following Systemic Blood-Neural Barrier Disruption
by: Flora Hui, et al.
Published: (2017-10-01)

Neurovascular Unit Dysfunction and Neurodegenerative Disorders
by: Xing Yu, et al.
Published: (2020-04-01)

Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics
by: Chaahat S.B. Singh, et al.
Published: (2021-09-01)

Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases
by: Caroline Coisne, et al.
Published: (2016-12-01)

Malignant Melanoma-Derived Exosomes Induce Endothelial Damage and Glial Activation on a Human BBB Chip Model
by: Peng Wang, et al.
Published: (2022-01-01)

Alzheimer’s and ABC transporters — new opportunities for diagnostics and treatment
by: Jens Pahnke, et al.
Published: (2014-12-01)

Glioblastoma Multiforme—A Look at the Past and a Glance at the Future
by: Jasmine L. King, et al.
Published: (2021-07-01)

Decreased plasma Aβ in hyperlipidemic APPSL transgenic mice is associated with BBB dysfunction
by: Tina eLöffler, et al.
Published: (2016-06-01)

Glial Cell-Based Vascular Mechanisms and Transplantation Therapies in Brain Vessel and Neurodegenerative Diseases
by: Yingying Zhao, et al.
Published: (2021-03-01)

Effects of erythropoietin combined with tissue plasminogen activator on the rats following cerebral ischemia and reperfusion
by: Rongliang Wang, et al.
Published: (2016-01-01)

Cooperation between neurovascular dysfunction and Aβ in Alzheimer’s disease
by: Niya Wang, et al.
Published: (2023-08-01)

Bisphenol A Inhibits the Transporter Function of the Blood-Brain Barrier by Directly Interacting with the ABC Transporter Breast Cancer Resistance Protein (BCRP)
by: Elin Engdahl, et al.
Published: (2021-05-01)

Alzheimer's disease pathology: pathways between chronic vascular risk factors and blood-brain barrier dysfunction in a cohort of patients with different types of dementia
by: Jinghuan Gan, et al.
Published: (2023-05-01)

Nanomedicine Against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence
by: Francesca Pederzoli, et al.
Published: (2019-11-01)

Albumin induces excitatory synaptogenesis through astrocytic TGF-β/ALK5 signaling in a model of acquired epilepsy following blood–brain barrier dysfunction
by: Itai Weissberg, et al.
Published: (2015-06-01)

Filter exchange imaging with crusher gradient modelling detects increased blood–brain barrier water permeability in response to mild lung infection
by: Yolanda Ohene, et al.
Published: (2023-04-01)